Grifols, S.A. P/E Ratio

Grifols, S.A. (GIKLY) currently reports a P/E ratio of 14.75. That is below the Healthcare sector average of 66.31. Use the charts on this page to explore Grifols, S.A.'s P/E ratio history and peer comparisons.

Grifols, S.A.'s P/E ratio of 14.75 is lower than the Healthcare sector average of 66.31. That is roughly 77.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Grifols, S.A.'s market price to a fundamental measure such as earnings, sales, or book value. At 14.75, GIKLY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 14.75, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 66.31. From there, open related valuation or income-statement pages for Grifols, S.A., and consider following GIKLY for alerts when major investors trade the stock.

Grifols, S.A. is classified in the Healthcare sector. On P/E ratio, it currently shows 14.75 versus a sector average near 66.31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GIKLY with unrelated industries.